The importance of clinician engagement in the HTA process
Join Alexandra Chambers & oncologist Dr. Craig Earle with CADTH’s pan-Canadian Oncology Drug Review (pCODR) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform cancer drug funding recommendations to enhance patient outcomes for Canadians.
3Sixty Public Affairs’ Bill Dempster will moderate this interactive webinar that will include opportunities for participants to participate in polling and ask questions.
Hosted by Bill Dempster, 3Sixty Public Affairs with Alexandra Chambers and Dr. Craig Earle
Tuesday, January 23rd 2018 – 1:00pm